NCT02158117View on ClinicalTrials.gov

Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Drug Overdose
Interventions
DRUG

nasal naloxone

one puff in one nostril with the subject is lying down

Trial Locations (1)

Unknown

Department of Circulation and Medical Imaging, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT02158117 - Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use | Biotech Hunter | Biotech Hunter